NAVILAS laser system focal laser treatment for diabetic macular edema-one year results of a case series

Open Ophthalmology Journal

Volumn 7, Issue , 2013, Pages 48-53

  Jung, Jesse J ^a,b,c,d   Gallego Pinazo, Roberto ^a,b,e   Lleó Pérez, Antonio ^f   Huz, Jonathan I ^a   Barbazetto, Irene A ^a,b,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^c EAR AND THROAT HOSPITAL   (United States)

^d Edward S Harkness Eye Institute   (United States)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL FRANCESC DE BORJA   (Spain)

Author keywords

Anti vegf; Bevacizumab; Diabetes; Focal laser photocoagulation; Macular edema; NAVILAS

Indexed keywords

BEVACIZUMAB; HEMOGLOBIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CASE STUDY; CENTRAL FOVEAL THICKNESS; CLINICAL ARTICLE; COHORT ANALYSIS; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; LARGEST SUBFIELD OF MACULAR THICKNESS; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; NAVIGATED RETINA LASER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL MACULAR VOLUME; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; DIABETIC PATIENT; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; MACULAR THICKNESS; MICROANEURYSM;

EID: 84884173800     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101307010048     Document Type: Article

References (14)

1. ETDRS Research Group. Photocoagulation for diabetic macular edema: ETDRS Report 1. Arch Ophthalmol 1985; 103(12): 1796-806.
2. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema. Ophthalmology 2012; 119: 789-801.
3. Blumenkranz MS. Optimal current and future treatments for diabetic macular oedema. Eye 2010; 24(3): 428-34
4. Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 2011; 118(6): 1119-24.
5. Kernt M, Cheuteu R, Vounotrypidis E, et al. Focal and panretinal photocoagulation with a navigated laser (NAVILAS ®). Acta Ophthalmol 2011; 89(8): e662-4.
6. Kozak I, Kim JS, Oster SF, Chhablani J, Freeman WR. Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina 2012; 32(5): 930-5.
7. Chalam KV, Murthy RK, Brar V, Radhakrishnan R, Khetpal V, Grover S. Evaluation of a Novel, Non Contact, Automated Focal Laser with Integrated (NAVILAS) fluorescein angiography for diabetic macular edema. Middle East Afr J Ophthalmol 2012; 19(1): 158-62.
8. Joussen A, Smyth N, Niessen C. Pathophysiology of diabetic macular edema. Dev Ophthalmol 2007; 39: 1-12.
9. Gogi D, Gupta A, Gupta V, Pandav SS, Dogra MR. Retinal microaneurysmal closure following focal laser photocoagulation in diabetic macular edema. Ophthalmic Surg Lasers 2002; 33(5): 362-7.
10. Ober MD, Kernt M, Cortes MA, Kozak I. Time required for navigated macular laser photocoagulation treatment with the Navilas ®. Graefes Arch Clin Exp Ophthalmol 2013; 251(4): 1049-53.
11. Kernt M, Cheuteu RE, Cserhati S, et al. Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Clin Ophthalmol 2012; 6: 289-96.
12. Bamroongsuk P, Yi Q, Harper CA, McCarty D. Delivery of photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital: comparisons with national clinical practice guidelines. Clin Exp Ophthalmol 2002; 30(2): 115-9.
13. Neubauer AS, Langer J, Liegl R, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol 2013; 7: 121-8.
14. Mitchell P, Bandello R, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118(4): 615-25.